We have devised a complementation assay in yeast to clone mammalian transcriptional activators and have used it to identify a human basic leucine-zipper transcription factor that we have designated Nrfl for NF-E2-related factor 1. Nrfl potentially encodes a 742-aa protein and displays marked homology to the mouse and human NF-E2 transcription factors. Nrfl activates tanscription via NF-E2 binding sites in yeast cells. The ubiquitous expression pattern of Nrfl and the range of promoters containing the NF-E2 binding motif suggest that this gene may play a role in the regulation of heme synthesis and ferritin genes.
Upstream from the e-globin gene are four erythroid-specific DNase I hypersensitive sites (HS1-4) collectively termed the locus control region (1) (2) (3) . Genetic results suggest that the locus control region functions as a powerful enhancer and is essential for the erythroid-specific expression of the globin genes (4) (5) (6) (7) (8) (9) . Among the HSs, enhancer activity appears to reside predominantly within HS2 and HS3 (10) (11) (12) (13) (14) (15) . Studies in transgenic mouse and transient transfection assays have localized the erythroid-specific enhancer activity within the 732-bp HindIII-Bgl II fragment of HS2. This fragment includes a direct sequence repeat (GCTGAGTCATGA1L GAGTCA) identified by in vitro and in vivo footprinting experiments (11, 16, 17) . The AP1 consensus sequence (TGAGTCA) plus the bases G and C 5' to it (GCTGAGTCA) have been shown to be an activator for the porphobilinogen deaminase gene and bind an erythroid-specific factor termed NF-E2 (18, 19) . This dimeric motif is necessary for high-level expression of erythroid-specific genes in transgenic mice and transient transfection experiments (10) (11) (12) .
By using a yeast expression system, we set out to clone cDNAs that encode proteins that bind to the tandem NF-E2/AP1 site and activate transcription. The cloning by complementation ofgenes from heterologous species in yeast has been described (20) (21) (22) ; however, this approach is limited by the availability of corresponding yeast mutants to isolate the gene of interest. To overcome this problem, we developed a yeast expression system in which the neomycin-resistance gene was placed under the control of the tandem NF-E2/AP1 motif. Expression of the neomycin-resistance gene is in turn dependent on the expression of transfected cDNAs that encode the appropriate activating proteins via the linked NF-E2/AP1 enhancer sequence. Using this yeast genetic selection strategy, we screened a human erythroleukemia cell line (K562) cDNA library constructed in a yeast expression vector and isolated a cDNA* that encodes a member of the basic leucine-zipper (bZIP) protein family that activates transcription via the NF-E2/AP1 binding site. The deduced amino acid sequence displays remarkable similarity to the transcription factors mouse NF-E2 (23) and human NF-E2
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MATERIALS AND METHODS
Nucleic Acid Cloning and Analysis. cDNA libraries were constructed (25) from mRNA prepared from hemin-treated K562 cells (40 AM for 24 h). A yeast expression library was generated (22) in plasmid pDB20. A phage libraries were generated in AGT10 and screened (25) . DNA sequencing was performed by a modified dideoxynucleotide chain-termination method using Taq DNA polymerase (Promega fmol DNA sequencing system). Sequence analyses were done using the GCG sequence analysis (26) . Total RNA from various cell lines were isolated, size-fractionated, and blotted on to nylon membranes (25) . Northern blots containing multiple human tissue RNA samples were purchased from Clontech. Hybridizations and washings were done by standard procedures (25) .
Yeast Strains, Transformations, Growth Conditions, and -GalactosidaseAssay. Standard yeast genetic methods were used (27) . JCN1 strain was constructed by transformation of Saccharomyces cerevisiae YPH303a (MATa leu2Al his3A200 trplA63 lys2-801 ura3-52 Gal3+) by electroporation with plasmid yCPN3Neo (see below) (27 In Vitro Translation and Immunoblots. In vitro expression of Nrfl was done using TnT reticulocyte system (Promega). Inserts containing Nrfl sequences were cloned downstream of the T7 promoter in the plasmid pBluescript SK+ (Stratagene).
Immunoblots were done with rabbit anti-Zip and anti-Term antibodies prepared by Caltag (South San Francisco, CA). Antibodies are against synthetic peptides corresponding to residues 652-666 and 728-742, respectively, of the Nrfl protein sequence. Horseradish peroxidase-conjugated goat anti-rabbit antibody was used as a secondary antibody and developed with diaminobenzidine (25) .
RESULTS
Cloning of Human Nrfl cDNA. Yeast strain JCN1 was transformed with a cDNA library constructed in the yeast expression vector pDB20 with cDNA derived from hemininduced K562 cell line. Double transformants were selected first for uracil and tryptophan prototrophy on tryptophanand uracil-deficient synthetic dextrose medium. The transformants were recovered and subsequently replated as pools to screen for neomycin-resistant colonies on a rich medium containing the antibiotic G418. We screened 100,000 double transformants, and several independent clones resistant to Proc. Natl. Acad. Sci. USA 90 (1993) the antibiotic G418 were identified. DNA from these clones was isolated and used for a second round of transfection in JCN1 to verify that the neomycin-resistant phenotype was indeed the result of expression from the transfected cDNA and not due to a random mutational event in the yeast cell allowing it to propagate in the presence of G418. Two clones were isolated and found to be identical.
Nrfl (Fig. 1) . The ORF is preceded by 11 in-frame stop codons and is followed by two overlapping polyadenylylation signals at extreme 3' end of the sequence. Thus, these findings suggest that the entire length of the cDNA has been obtained.
The predicted amino acid sequence contained a region near the C terminus with marked similarity to the bZIP family of transcription factors. This region is characterized by heptad repeats of leucine and hydrophobic residues within a putative amphipathic helical domain of 40 aa and is preceded by a 30-aa domain rich in arginine and lysine residues (Fig. 2) . Protein sequence comparison found similarity closest to a Drosophila bZIP protein termed "cap and collar" (CNC) (24) and the mouse (23) 
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Characterization of the Protein Product Encoded by Nrfl. Conceptual translation of the ORF from the first methionine residue at nt 929 predicts a protein of 81 kDa. However, only the in-frame ATGs at nt 1799 and 1814 are in a good context for initiation based on Kozak's rules (33) . If translation does indeed begin from these internal AUG codons, the proteins will have a predicted size of 50 kDa. Interestingly, in vitro transcription and translation of the entire coding region of Nrfl revealed two products-a major product of 110 kDa and a minor product of 65 kDa (Fig. 3a, lane 1) . Translation of a plasmid containing the partial clone, E517, lacking nt 1-1780 that contains the first ATG codon of Nrfl, resulted in a shorter peptide of 65 kDa (Fig. 3a, lane 2) . We presume that the minor 65-kDa product detected from translation of the full-length clone was derived from one of the internal methionines at nt 1799 or 1814. The disparity between the predicted sizes of 81 kDa and 50 kDa and the actual sizes of 110 kDa and 65 kDa, respectively, detected by SDS/PAGE may be due to the clustering of charged amino acids and serine residues in the protein that may cause them to migrate aberrantly.
Immunoblot experiments using rabbit polyclonal antibodies against two synthetic peptides (see Fig. 3b ) were carried out to detect the endogenous Nrfl protein in K562. A major protein with molecular mass of =65 kDa was detected migrating with the shorter 35S-labeled in vitro-transcribed and translated product (Fig. 3b, lane 2) . No specific polypeptide corresponding to the longer 110-kDa product derived from the in vitro transcription and translation of the plasmid containing the entire coding region was detected (Fig. 3b,  lane 1) . Absence of the larger protein may be due to differential usage of translational initiation or post-translational processing of a larger protein precursor. It is possible that the larger polypeptide predicted from the utilization of the first methionine triplet at nt 929 is by-passed in the K562 cell but served efficiently as the translational start site in an in vitro system or other cell types. We infer from these results that the endogenous Nrfl protein in K562 can be derived entirely from sequence information starting from nt 1799, by-passing the first AUG codon and potential coding information for an additional 286 aa, and that the encoded 50-kDa molecule migrates at 65 kDa.
Expression of Nrfl mRNA in Human Tissues and Cell Lines. Hybridization of RNA blots with DNA probes derived from either the 5' or 3' end of the Nrfl cDNA detected two transcripts of -5 kb in the erythroid (K562, KU24410, and HEL) and nonerythroid (RAJI, HPBALL, 293, HELA, and Plc/Prf/5) cell lines tested (Fig. 4a) . The molecular basis of these two transcripts may be due to alternate usage of polyadenylylation signals. In addition to the canonical AATAAA, the 3' untranslated region contains an unusual polyadenylylation motif (ATGAAA) at nt 4394-4400 identical to the m-junD motif (34) and thus provides alternative termination sites. Northern blots containing poly(A)+-selected RNA from various human tissues were also examined. High levels of transcripts were seen in heart, skeletal muscle, kidney, lung, and ovary, and lower levels were detected in placenta, liver, brain, pancreas, spleen, thymus, prostate, testis, small intestine, colon, and peripheral blood leukocytes (Fig. 4b) Li-Gial --ativity control ofCYC) minimal promoterplus or minus three tandem copies of NF-E2/AP1 binding site, designated yCPLN3 and yCPLASS, respectively, in place of the CYC upstream activation sequence elements. Yeast expression plasmid pDB517 containing the original clone isolated from the crosscomplementation experiment described above was cotransformed with the reporter constructs. A cDNA clone designated pDBUT and isolated during selection for double transformants but incapable ofconferring resistance on subsequent platings of JCN1 on neomycin-supplemented plates was used as a negative control. As shown in Fig. 5 endogenous and in vitro-translated proteins display similar mobility in SDS/PAGE. Thus, we believe that this protein migrates anomolously due to intrinsic properties. Atypical behavior in SDS/PAGE gels has been observed for c-fos, c-myc, and protein 4.1 (35) (36) (37) .
The ability of Nrfl to activate transcription through the tandem NF-E2/AP1 repeat in HS2 was confirmed in K562 (J.Y.C., unpublished data) and yeast cells. Expression of Nrfl from the transfected plasmid increased the expression of a cotransfected reporter plasmid in a NF-E2/APl-motifdependent manner. A striking feature of the region immediately N-terminal to the bZIP domain is the abundance of acidic residues flanked by multiple serine and threonine residues that is reminiscent of activation domains of Spl and Gal4 (31) . A marked reduction of activity was seen when this region was truncated (J.Y.C., unpublished data).
In contrast to NF-E2, which is restricted to the erythroid, megakaryocytic, and mast cell lineages (23) , we have found that Nrfl is expressed ubiquitously. Thus, the cellular distribution of Nrfl and NF-E2 shows an interesting parallel to the GATA-binding protein family (38) . Although expression of GATA-1 and murine NF-E2 is restricted to similar lineages, other members of the family such as GATA-2, 3, and 4 are more widely expressed. Whether both Nrfl and NF-E2 demonstrate similar binding specificities is yet to be determined. However, the remarkable conservation of the putative DNA binding domain (basic region) between NF-E2 and Nrfl suggests that they probably bind to very similar, if not identical, sequences. What then is the mechanism for transactivating specificity between Nrfl and NF-E2? Perhaps sequences outside the bZIP domains impart specificity by providing appropriate protein-protein interaction in the transcription complex. Such a mechanism has been postulated for Octl and Oct2 proteins (39) . Alternatively, the specificity may be determined by association with their respective dimerization partner, as Nrfl and NF-E2 are bZIP proteins. The ubiquitous distribution of Nrfl raises the question as to what role, ifany, it plays in globin gene expression. The range of promoters containing a NF-E2 binding sites includes several genes involved in the synthesis of heme and the iron-storage protein ferritin (23) . As heme and iron play diverse roles including oxygen transport, prostaglandin synthesis, inactivation of oxygen radicals, and as prosthetic groups in cytochrome P450 enzymes, they are found in all tissues (40) . Hence, we speculate that Nrfl may play a role in the gene expression of heme biosynthetic enzymes and the iron storage protein ferritin.
